A61K 2239/24
Dimerizable cars
Official title: Dimerizable CARs; CARs with adapter
A61K2239/24 (Dimerizable cars) appears on 17 US grants and 62 published applications in this corpus.
Search patents in A61K- Granted patents
- 17
- Published applications
- 62
- Assignees
- 34
- Inventors
- 140
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 2 |
| 2017 | 2 | 3 |
| 2018 | 1 | 3 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 2 | 8 |
| 2022 | 1 | 2 |
| 2023 | 3 | 10 |
| 2024 | 2 | 12 |
| 2025 | 3 | 15 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Heterodimeric inactivatable chimeric antigen receptors20 Jan 2026US 12,528,847 B2Ecole Polytechnique Federale de Lausanne
- Chimeric antigen receptor and methods of use thereof29 Jul 2025US 12,371,466 B2The Regents of the University of California
- D-domain containing polypeptides and uses thereof24 Jun 2025US 12,338,294 B2Arcellx, Inc.
- Chimeric antigen receptor and application thereof11 Feb 2025US 12,221,475 B2CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
- Chimeric antigen receptor and methods of use thereof10 Dec 2024US 12,161,672 B2The Regents of the University of California
- Switch receptors1 Oct 2026US 2026/0295042 A1Hoffmann-La Roche Inc.
- Inhibitors of nfat and nfkb signaling for improving immune cell function30 Apr 2026US 2026/0116933 A1Memorial Hospital for Cancer and Allied Diseases
- Small molecule adapter regulated, target specific chimeric antigen receptor bearing t cells (smart cars)15 Jan 2026US 2026/0015402 A1Yale University
- D-domain containing polypeptides and uses thereof18 Dec 2025US 2025/0382380 A1Arcellx, Inc.
- Improved glycan-dependent immunotherapeutic bi-specific proteins with longer half-life27 Nov 2025US 2025/0361318 A1The Regents of the University of California
Most cited
By later US patents
- Chimeric antigen receptor and methods of use thereof60US 9,587,020 B2The Regents of the University of California · 2017
- Regulatable chimeric antigen receptor24US 10,287,354 B2Novartis AG · 2019
- Chimeric antigen receptor and methods of use thereof24US 9,821,012 B2The Regents of the University of California · 2017
- Chimeric antigen receptor and methods of use thereof15US 10,105,391 B2The Regents of the University of California · 2018
- Chimeric antigen receptor and methods of use thereof6US 10,888,581 B2The Regents of the University of California · 2021